Article page

Innovative biotechnologies of immunobiological pharmaceuticals in the maintenance of health and life quality of the country's population


DOI:

Full Text:


Abstract

The first national non-waste technology of innovative immunoglobulin medicines obtaining with corrections according to international quality requirements was proposed and tested. The trial was carried out with consideration of blood sampling region of the specific country, with substantiation of their complex application concept in combination with interferon at rectal or vaginal application, allowing offering a number of immunobiological medicines non conceding to foreign analogues and original in some cases for introduction in health practice. The usage of immunoglobulins, finished dosage forms on the base of native (leukocytic) or recombinant human interferon and also of complex immunobiological medicines with their incorporation, accumulating positive properties of monotherapy in specific finished dosage form, seems perspective and pathogenetically justified.


Для цитирования:

For citation:

Refbacks

  • Refbacks are not listed


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 3.0 License.

ISSN: (Print)
ISSN: (Online)